The retail cost of Humira can vary significantly based on factors such as insurance coverage, pharmacy, and dosage. Without insurance, the average monthly cost for a single pen of Humira (40 mg/0.4 mL) is approximately $6,900 to $7,000 [1]. Some sources indicate a list price that can reach as high as $8,000 per month [2].
How much does Humira cost with insurance?
Insurance coverage greatly impacts the out-of-pocket cost for Humira. Patients with commercial insurance often have copay assistance programs available, which can reduce their monthly expenses. These programs may limit copays to as low as $5 per month for eligible patients [3]. However, this is contingent on the specific insurance plan and the drug formulary. Medicare and Medicaid coverage also affects patient costs, with varying copayments and deductibles depending on the specific government program.
When does Humira's patent expire?
Humira's primary US patents have expired, with the last of the major ones expiring in 2023 [4]. This patent expiration has opened the door for biosimilar versions of Humira to enter the market.
What are the biosimilar options for Humira?
Following the patent expirations, several biosimilar versions of Humira have become available. These include products like Amjevita, Cyltezo, Hyrimoz, and Hulio, among others [4]. Biosimilars are highly similar to the reference product (Humira) and have no clinically meaningful differences in terms of safety, purity, and potency [5]. The introduction of these biosimilars is expected to increase competition and potentially lower costs. DrugPatentWatch.com tracks these patent expirations and the emergence of biosimilars [4].
How do Humira biosimilars affect drug pricing?
The availability of biosimilars is anticipated to drive down the cost of adalimumab (the active ingredient in Humira). While the exact price reductions are still unfolding, initial pricing for some biosimilars has been set at a discount compared to the brand-name Humira [6]. This competitive pressure aims to make the treatment more accessible.
What are the approved uses for Humira?
Humira is approved to treat a range of chronic inflammatory conditions. These include moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis [7]. It is also used for moderate to severe hidradenitis suppurativa and non-infectious uveitis [7].
What are the potential side effects of Humira?
Like all medications, Humira can cause side effects. Common side effects include injection site reactions (redness, itching, pain), upper respiratory infections, headaches, and rash [7]. More serious risks include serious infections, which can be life-threatening, and the potential for certain cancers. Patients should discuss all potential risks and benefits with their healthcare provider [7].
Sources:
[1] https://www.goodrx.com/humira
[2] https://www.singlecare.com/prescription/humira/cost
[3] https://www.humira.com/help-with-cost
[4] https://drugpatentwatch.com/blog/adalimumab-patent-cliff-approaching
[5] https://www.fda.gov/news-events/public-statements-keyframes/understanding-biosimilars
[6] https://www.cbsnews.com/news/humira-costs-drug-companies-launch-cheaper-versions-of-blockbuster-arthritis-drug/
[7] https://www.humira.com/what-is-humira/how-humira-works